“Introduction of the competition is the best way to lower the prices. Patent protection is the major barrier to the generic production of these medicines,” SJM said in a statement Sunday, proposing the government to use the public health safeguards in the Patents Act and permit more companies to produce these medicines.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tklxoZ
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Cap Covid-19 medicines, vax prices, issue compulsory license to scale up output: RSS-affiliate SJM to govt
0 comments:
Post a Comment